Mr Daniel Vulkan, BA MSc

Profile

I joined the Wolfson Institute in 2016, after completely MSc in Social Research Methods from the London School of Economics & Political Science in 2014. I have also previously worked as an actuary and as a demographic researcher.

I am a statistician in the Centre for Prevention, Detection and Diagnosis. I am also a part of the NIHR Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis.

Research

Publications

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis (The Lancet Regional Health – Europe, 2021) 

Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial (British Journal of General Practice, 2021) 

First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer (British Journal of Cancer, 2020) 

Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial (The Lancet Oncology, 2020) 

• Duffy SW, Hudson S, Vulkan D et al. (2022), Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake? $nameOfConference

  
  

  DOI: 10.1177/09691413211066476

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77785
• Duffy SW, Seedat F, Kearins O et al. (2022), The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation $nameOfConference

  
  

  DOI: 10.1038/s41416-022-01714-9

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77784
• Field JK, Vulkan D, Davies MPA et al. (2021), Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis $nameOfConference

  
  

  DOI: 10.1016/j.lanepe.2021.100179

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75621
• Laake JP, Vulkan D, Quaife SL et al. (2021), Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial $nameOfConference

  
  

  DOI: 10.3399/bjgp20X713489

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71602
• Kaushal A, Hirst Y, Tookey S et al. (2020), Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population $nameOfConference

  
  

  DOI: 10.1016/j.ypmed.2020.106268

  
  
• Field JK, Vulkan D, Davies MPA et al. (2020), Liverpool lung project lung cancer risk stratification model: Calibration and prospective validation $nameOfConference

  
  

  DOI: 10.1136/thoraxjnl-2020-215158

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68653
• Duffy S, Vulkan D, Cuckle H et al. (2020), Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: Long-term follow-up of the uk age rct $nameOfConference

  
  

  DOI: 10.3310/hta24550

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68564
• Duffy SW, Vulkan D, Cuckle H et al. (2020), Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial $nameOfConference

  
  

  DOI: 10.1016/S1470-2045(20)30398-3

  
  
• Chapman D, Poirier V, Vulkan D et al. (2020), First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer. $nameOfConference

  
  

  DOI: 10.1038/s41416-020-0947-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67124
• Ghimire B, Maroni R, Vulkan D et al. (2020), Erratum to “Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme” (Lung Cancer (2019) 134 (66–71), (S0169500219304702), (10.1016/j.lungcan.2019.05.026)) $nameOfConference

  
  

  DOI: 10.1016/j.lungcan.2019.10.007

  
  
• Ghimire B, Maroni R, Vulkan D et al. (2019), Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme $nameOfConference

  
  

  DOI: 10.1016/j.lungcan.2019.05.026

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/58971
• Aarts AMWM, Duffy SW, Geurts SME et al. (2019), Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer $nameOfConference

  
  

  DOI: 10.1016/j.breast.2019.03.003

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64452
• von Wagner C, Hirst Y, Tookey S et al. (2018), Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population. $nameOfConference

  
  

  DOI: 10.1136/bmjopen-2018-022263

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/39448
• Burnside ES, Vulkan D, Blanks RG et al. (2018), Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study. $nameOfConference

  
  

  DOI: 10.1148/radiol.2018171539

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/58642
• Aarts AMWM, Duffy SW, Geurts SME et al. (2018), Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands) $nameOfConference

  
  

  DOI: 10.1177/0969141318814869

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54759
• Benton SC, Butler P, Allen K et al. (2017), GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. $nameOfConference

  
  

  DOI: 10.1038/bjc.2017.129

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/33423